PDPGA and its synthetic monomer exerted anti-cancer efficacy in vitro and in human prostate cancer (PCA) cells. Overall, this study identifies PDPGA as a potent agent against PCA without
this tubulin binding agent in various types of solid tumors like prostate, breast, lung, and brain cancer. Moreover, our group also reported several new analogues of noscapine which
representing on full nine human systems as leukemia, melanoma and cancers of lung, colon, brain, breast, ovary, kidney and prostate in accordance with their applied protocol (used SRB assay ... less sensitivity against…
oral, twice-daily (BID) TAK- 700 in patients (pts) with metastatic, castration-resistant prostate cancer (MCRPC). Secondary objectives include assessment of TAK-700 efficacy, as shown by prostate-specific antigen
drug that is mainly indicated for the treatment of hormone-related cancers like prostate cancer. Th e current dosage forms of goserelin-acetate - AstraZeneca?s Zoladex
other human diseases. TMPRSS2- ERG fusion also occurs in more than 50% of prostate cancer. Erg protein is required for defi nitive hematopoiesis, adult hematopoietic stem cell function ... complexed form and to develop…
various cancer cell lines including MIA PaCa-2 pancreatic, DU145 prostate, HL-60 leukemia and Caco-2 colon cancers. Dammarane triterpenoid 1 showed good anti-proliferative activity on MIA PaCa
Transrectal prostate biopsy (TRUS) is a commonly preformed procedure to diagnose prostate cancer. It is associated with certain morbidities some of which are serious like urinary tract infection (UTI) leading
glycosylation. Currently, in Cuba this vaccine has being evaluated in patients with refractory prostate cancer. Her1-ECD molecule (used for the Cuban clinical trials are obtained from culture supernatant
modality for age-related diseases such as cancer. In multiple preclinical breast cancer and prostate cancer models, our laboratory has shown that caloric restriction can be added to radiation
anticancer potential of ART, the exact mechanism of action of this drug in cancer still remains unclear. However, one of the most crucial and unsolved aspects of DDS containing ... deals with the use of electrospun…
early relapse will maintain recurrent themes using monotherapy. Our preclinical study demonstrated that terminal cancer patient�s lymphocytes can be converted into effective cytotoxic T-lymphocytes in vitro killing…
therapeutic use. Recently, we have been evaluating oral vaccines for cancer such as HPV, melanoma, ovarian, breast and prostate with encouraging results
carriers of tumor antigens helps to sidestep the dysfunction of endogenous DCs in cancer patients and allows for controlled delivery of �signal 3� that induces T cell eff ector functions ... phase I/II clinical trials…
antitumor effect in therapeutic settings we have treated either immunodeficient mice bearing human cancer xenografts or transgenic mice that spontaneously develop tumors expressing TAA. T-bodies effectively rejected…
reduces the risk of heart attack, inflammatory disorders, arthrosclerosis and inhibits growth of prostate and breast cancers. Flax seed is the richest agricultural source of the essential fatty acid
Luteinizing Hormone Releasing Hormone (LHRH) as a peptide antigen to control fertility and treat prostate cancer. The anti-LHRH vaccine constructs have shown promising results, eliciting antibodies against LHRH
pursue a less studied strategy of using PSMA displaying M13 bacteriophage for vaccination against prostate cancer. Bacteriophage vaccine are able to induce both humoral and cellular immune response, therefore ... design…
anti-cancer efficacy in vitro and in vivo against androgen-dependent and -independent human prostate cancer (PCA) cells via targeting androgen receptor, cell cycle arrest and apoptosis without any toxicity
focused on the development of precision medicine-driven interventions to prevent obesity-related cancers and improve outcomes. Our team was the first to demonstrate that inflammation of breast white adipose ... organ…
proteomic and methylomic analyses from the neoplastic cell lines MDA-MB-231 breast cancer, PC-3 prostate carcinoma, MG-63 and U2-OS osteosarcoma and HMC-1 mast cell leukemia ... TYMS, and ANLN and the upregulation of…
Naldi I et al. (2014) Novel epigenetic target therapy for prostate cancer: a preclinical study. PlosOne 9(5): e98101 3. Taranta M et al. (2011) Magnetically driven bioreactors
CA125, CA15-3, PSA, CA19.9 and CEA derived from ovarian, breast, prostate, pancreatic and colon cancer specific cell line, respectively. Interestingly, we successfully translated the cell line antigen based data
case studies examined feasibility and outcome of DC-based tumor vaccination for patients with prostate cancer (n=5), breast cancer (n=2), cervical cancer (n=1), gastric cancer ... resulted in a significant reduction in…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.